home > drugs a-z list > neoprofen (ibuprofen lysine injection) drug center > neoprofen (ibuprofen lysine injection) drug - warnings and precautions

Included as part of the PRECAUTIONS section.

General

There are no long-term evaluations of the infants treated with ibuprofen at durations greater than the 36 weeks post-conceptual age observation period. Ibuprofen's effects on neurodevelopmental outcome and growth as well as disease processes associated with prematurity (such as retinopathy of prematurity and chronic lung disease) have not been assessed.

Infection

NeoProfen (ibuprofen lysine injection) may alter the usual signs of infection. The physician must be continually on the alert and should use the drug with extra care in the presence of controlled infection and in infants at risk of infection.

Platelet Aggregation

NeoProfen (ibuprofen lysine injection) , like other non-steroidal anti-inflammatory agents, can inhibit platelet aggregation. Preterm infants should be observed for signs of bleeding. Ibuprofen has been shown to prolong bleeding time (but within the normal range) in normal adult subjects. This effect may be exaggerated in patients with underlying hemostatic defects (see CONTRAINDICATIONS).

Bilirubin Displacement

Ibuprofen has been shown to displace bilirubin from albumin binding-sites; therefore, it should be used with caution in patients with elevated total bilirubin.

Administration

NeoProfen (ibuprofen lysine injection) should be administered carefully to avoid extravascular injection or leakage, as solution may be irritating to tissue.

Last reviewed on RxList: 1/20/2010
This monograph has been modified to include the generic and brand name in many instances.